Clinical Trials Browser

Terminated × Breast Neoplasms × Naltrexone × Clear all

NCT00379197 2017-12-28

Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer

Phase 2 Terminated

13 enrolled 4 charts

Breast Neoplasms